These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27701873)

  • 1. Adjuvant therapy for resected biliary tract cancer: a review.
    Doherty MK; Knox JJ
    Chin Clin Oncol; 2016 Oct; 5(5):64. PubMed ID: 27701873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of adjuvant therapy for biliary tract cancer].
    Kato A; Miyazaki M
    Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Therapy for Biliary Tract Cancers.
    Horgan AM; Knox JJ
    J Oncol Pract; 2018 Dec; 14(12):701-708. PubMed ID: 30537458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.
    Ghidini M; Tomasello G; Botticelli A; Barni S; Zabbialini G; Seghezzi S; Passalacqua R; Braconi C; Petrelli F
    HPB (Oxford); 2017 Sep; 19(9):741-748. PubMed ID: 28684194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of biliary tract carcinomas].
    Delbaldo C; Laurent A; Grenier J; Cherqui D; Luciani A; Piedbois P
    Rev Prat; 2009 Apr; 59(4):469-73. PubMed ID: 19462864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for combined resection and reconstruction of the hepatic artery in biliary tract carcinoma].
    Endo I; Masunari H; Sugita M; Morioka D; Tanaka K; Togo S; Sekido H; Yoshida T; Shimada H
    Nihon Geka Gakkai Zasshi; 2001 Nov; 102(11):820-5. PubMed ID: 11729649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
    Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
    Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
    J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
    Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
    Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
    Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100334. PubMed ID: 33592563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
    Song S; Yang W; Tian H; Gong S; Lei C; Lv K; Lu T; Cheng Q; Yang K; Guo T
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101788. PubMed ID: 34389530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in biliary malignancy.
    Groot Koerkamp B; Fong Y
    J Surg Oncol; 2014 Oct; 110(5):585-91. PubMed ID: 25250887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant arterial infusion chemotherapy for patients with biliary cancer].
    Takeda Y; Hasuike Y; Kashiwazaki M; Tsujinaka T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1835-7. PubMed ID: 15553731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of biliary tract cancers.
    Fairweather M; Balachandran VP; D'Angelica MI
    Chin Clin Oncol; 2016 Oct; 5(5):63. PubMed ID: 27829277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival in resected biliary malignancies.
    Nakeeb A; Tran KQ; Black MJ; Erickson BA; Ritch PS; Quebbeman EJ; Wilson SD; Demeure MJ; Rilling WS; Dua KS; Pitt HA
    Surgery; 2002 Oct; 132(4):555-63; discission 563-4. PubMed ID: 12407338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions.
    Anderson C; Kim R
    Cancer Treat Rev; 2009 Jun; 35(4):322-7. PubMed ID: 19147294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality Management of Localized Biliary Cancer.
    Ashai N; Prasad P; Rajdev L
    Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.